NCT04971226 2026-03-10A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPNovartisPhase 3 Active not recruiting406 enrolled 18 charts 1 FDA
NCT03448393 2025-06-04CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed54 enrolled 24 charts